The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Acceleron Pharma's share price is $178.75.
Acceleron Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021 was $1.86. Hence, Acceleron Pharma's PS Ratio for today is 96.15.
Warning Sign:
Acceleron Pharma Inc stock PS Ratio (=96.15) is close to 2-year high of 96.15
The historical rank and industry rank for Acceleron Pharma's PS Ratio or its related term are showing as below:
XLRN'
s PS Ratio Range Over the Past 10 Years
Min: 6.69 Med: 64.27 Max: 188.26
Current: 96.15
During the past 10 years, Acceleron Pharma's highest PS Ratio was 188.26. The lowest was 6.69. And the median was 64.27.
XLRN's PS Ratio is not ranked
in the Biotechnology industry.
Industry Median: 8.98
vs XLRN: 96.15
Acceleron Pharma Inc revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Acceleron Pharma was -4.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 69.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 23.30% per year.
During the past 10 years, Acceleron Pharma's highest 3-Year average Revenue per Share Growth Rate was 69.60% per year. The lowest was -50.40% per year. And the median was -10.40% per year.
Back to Basics: PS Ratio
Acceleron Pharma PS Ratio Historical Data
The historical data trend for Acceleron Pharma's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Acceleron Pharma's PS Ratio
For the Biotechnology subindustry, Acceleron Pharma's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acceleron Pharma's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Acceleron Pharma's PS Ratio distribution charts can be found below:
* The bar in red indicates where Acceleron Pharma's PS Ratio falls into.
Acceleron Pharma PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Acceleron Pharma's Share Price of today is $178.75. Acceleron Pharma's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.86.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Acceleron Pharma PS Ratio Related Terms
Thank you for viewing the detailed overview of Acceleron Pharma's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Acceleron Pharma (Acceleron Pharma) Business Description
Acceleron Pharma is a biotechnology company focused on the discovery, development, and commercialization of novel therapies. The company's research focuses on key natural regulators of cellular growth and repair. Acceleron generates its revenue through collaboration, licensing, and research arrangements with collaboration partners for the development and commercialization of therapeutic candidates. The company sometimes uses contract research organizations and research institutions outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XLRN has been successfully added to your 